-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Celestica, Raises Price Target to $414

Benzinga·10/28/2026 15:28:54
Listen to the news
Barclays analyst Tim Long maintains Celestica (NYSE:CLS) with a Overweight and raises the price target from $406 to $414.